AVELOX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Avelox, and when can generic versions of Avelox launch?
Avelox is a drug marketed by Bayer Hlthcare and is included in two NDAs.
The generic ingredient in AVELOX is moxifloxacin hydrochloride. There are eighteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the moxifloxacin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Avelox
A generic version of AVELOX was approved as moxifloxacin hydrochloride by TEVA PHARMS USA on February 18th, 2014.
Summary for AVELOX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
Clinical Trials: | 82 |
Patent Applications: | 4,443 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for AVELOX |
What excipients (inactive ingredients) are in AVELOX? | AVELOX excipients list |
DailyMed Link: | AVELOX at DailyMed |
![AVELOX drug patent expirations Drug patent expirations by year for AVELOX](/p/graph/s/t/AVELOX-patent-expirations.png)
![Drug Prices for AVELOX](/p/graph/drug-price/AVELOX.png)
![Drug Sales Revenue Trends for AVELOX](/p/graph/drug-sales-revenues/AVELOX.png)
Recent Clinical Trials for AVELOX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Daiichi Sankyo, Inc. | Phase 4 |
Usona Institute | Phase 1 |
SAMI Pharmaceutical, Karachi Pakistan | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for AVELOX
US Patents and Regulatory Information for AVELOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | AVELOX | moxifloxacin hydrochloride | TABLET;ORAL | 021085-001 | Dec 10, 1999 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bayer Hlthcare | AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER | moxifloxacin hydrochloride | SOLUTION;INTRAVENOUS | 021277-001 | Nov 30, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AVELOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Hlthcare | AVELOX | moxifloxacin hydrochloride | TABLET;ORAL | 021085-001 | Dec 10, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Bayer Hlthcare | AVELOX | moxifloxacin hydrochloride | TABLET;ORAL | 021085-001 | Dec 10, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Bayer Hlthcare | AVELOX | moxifloxacin hydrochloride | TABLET;ORAL | 021085-001 | Dec 10, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AVELOX
See the table below for patents covering AVELOX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 1128831 | ⤷ Try a Trial | |
Slovenia | 780390 | ⤷ Try a Trial | |
Cuba | 23260 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for AVELOX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0780390 | PA2004012,C0780390 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: MOXIFLOXACINI HYDROCHLORIDUM (1-CIKLOPROPIL-6-FLUOR-1,4-DIHIDRO-8-METOKSI-7-((4AS, 7AS)-OKTAHIDRO-6H-PIROLO(3,4-B)PIRIDIN-6-IL)-4-OKSO-3-CHINOLINKARBOKSIRUGSTIES HIDROCHLORIDAS); REGISTRATION NO/DATE: 04/8383/3 20040309 |
0350733 | 2001C/030 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MOXIFLOXACINE CHLORHYDRATE (CORRESPONDANT A MOXIFLOXACINE); NATL. REGISTRATION NO/DATE: 187 IS 328 F 3 20010507; FIRST REGISTRATION: DE 45263.00.00 19990621 |
0350733 | SPC/GB03/034 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: MOXIFLOXACIN AND PHARMACEUTICALLY USABLE HYDRATES AND ACID ADDITION SALTS THEREOF AND THE ALKALI METAL, ALKALINE EARTH METAL, SILVER AND GUANIDINIUM SALTS OF THE UNDERLYING CARBOXYLIC ACIDS AND THE RACEMATES THEREOF; REGISTERED: DE 45263.00.00 19990621; UK PL 000 10/0291 20030313 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |